Filters
Other countries
Results: 1 to 11 of 11
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CFI - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 3 | 1 |
|
CFI - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Macular Dystrophy Panel Invitae United States | 66 | 36 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Invitae United States | 755 | 562 |
|
Invitae Complement Deficiency Disorders Panel Invitae United States | 35 | 22 |
|
Invitae Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies Panel Invitae United States | 25 | 13 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 527 | 338 |
|
Invitae Primary Immunodeficiency Panel Invitae United States | 552 | 424 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Hemolytic uremic syndrome panel. 9-gene NGS panel. Genologica Medica Spain | 19 | 9 |
|
Complement factor I deficiency: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Results: 1 to 11 of 11
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.